Publications by authors named "Sharmini Balashanker"

Claim this Profile
A
Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
Bee Kim Tan, Siew Siang Chua, Li-Chia Chen, Kian Meng Chang, Sharmini Balashanker

J Oncol Pharm Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial.
Bee Kim Tan, Siew Siang Chua, Li-Chia Chen, Kian Meng Chang, Sharmini Balashanker

Support Care Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial.
Bee Kim Tan, Siew Siang Chua, Li-Chia Chen, Kian Meng Chang, Sharmini Balashanker

Support Care Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study.
Bee Kim Tan, Seng Beng Tan, Li-Chia Chen, Kian Meng Chang, Siew Siang Chua, Sharmini Balashanker

Patient Prefer Adherence· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis